AUBN AUBN
Company Profile ↓Company Overview
AUBN (AUBN) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Trades at an undemanding P/E of 12.6.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $619.00K (+0.8% YoY).
- Trailing 12 Months Year-on-year growth — revenue +0.8%.
- 5-Year Trend Long-term compounding — revenue CAGR -2.3%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -2.31% |
| 1 Year: | 0.81% |
Stock Price Performance
| 1 Year: | +3.43% |
| 6 Months: | +4.62% |
| 3 Months: | +12.82% |
| 1 Month: | +5.00% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)50.13 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Revenue declined at -2.3% CAGR over 5 years.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2018 | Jun 2018 | Sep 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 179.00K | 182.00K | 192.00K | 184.00K | 176.00K | 182.00K | 172.00K | 126.00K | 139.00K | 132.00K | 138.00K | 149.00K | 142.00K | 146.00K | 158.00K | 154.00K | 154.00K | 148.00K | 156.00K | 153.00K | 154.00K | 155.00K | 152.00K | 154.00K | 153.00K |
| Diluted EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.50 | 0.44 | - | 0.64 | 0.63 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 746.00K | 749.00K | 717.00K | 585.00K | 566.00K | 598.00K | 603.00K | 614.00K | 619.00K |
| Diluted EPS | - | - | - | - | - | - | - | 1.83 | 2.08 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 763.83M | 776.22M | 759.83M | 751.34M | 789.23M | 817.19M | 831.94M | 853.38M | 818.08M | 827.88M | 956.60M | 1.11B | 1.02B | 975.25M | 977.32M | 1.02B |
| Total Equity | 57.13M | 56.18M | 56.37M | 65.42M | 70.15M | 64.48M | 75.80M | 79.95M | 82.18M | 86.91M | 89.06M | 98.33M | 107.69M | 103.73M | 68.04M | 76.51M | 78.29M | 92.05M |
| Cash & Equivalents | - | - | 11.43M | 12.39M | 18.76M | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Long Term Debt | - | - | 93.33M | 85.31M | 47.22M | 12.22M | 12.22M | 7.22M | 3.22M | 3.22M | - | - | - | - | - | - | - | - |
| Total Liabilities | - | - | 707.46M | 710.80M | 689.68M | 686.86M | 713.43M | 737.24M | 749.77M | 766.48M | 729.02M | 729.55M | 848.91M | 1.00B | 955.85M | 898.75M | 899.03M | 926.74M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 4.32M | 11.88M | 14.09M | 15.06M | 13.72M | 10.53M | 10.85M | 10.49M | 9.40M | 12.14M | 10.85M | 9.73M | 12.32M | 10.98M | 11.90M | 10.81M | 12.35M |
| Investing Cash Flow | -54.10M | 11.25M | 18.30M | 19.11M | -13.06M | -3.98M | - | - | -39.61M | -12.05M | 24.09M | -102.92M | -118.84M | -90.96M | 91.38M | 16.85M | 18.80M |
| Financing Cash Flow | 25.74M | -14.10M | 1.61M | -27.65M | -8.39M | 22.73M | - | - | 14.46M | -40.54M | -7.57M | 113.33M | 150.21M | -49.03M | -59.16M | -5.68M | 23.33M |
| Capital Expenditure | - | - | - | - | - | - | - | - | - | - | - | - | -20.18M | -7.05M | -418.00K | -2.09M | -1.49M |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - | - | - | -7.86M | 3.93M | 11.48M | 8.72M | 10.86M |
| Share Buybacks | 90.00K | 9.00K | 0 | 0 | 0 | - | - | - | - | 0 | 2.72M | 0 | 1.62M | 504.00K | 229.00K | 0 | - |
Ratios (Annual)
Figures in %.
| Metric | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - | - | - | - | - |
| Net Margin % | - | - | - | - | - | - | - | - | - |
| ROE % | - | - | - | - | - | - | - | - | - |
| ROCE % | - | - | - | - | - | - | - | - | - |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for AUBN
(AUBN) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMiyAFBVV95cUxPajFMdmM4Slc0akNVaE9WOVh0N3dXQ0hQbUFZRUxwY1ZkYTUtNEZMbzN4Ty0xZkl0ZWZfNzU5dGFsRGlROGlZZV9FOU5WSkdtV09QTjBXeDNjWlBlRGtmSi1Fa0VPdU5XSHNIeVhfSEw0cVBQeTE3WHlyLXA2VVB2NUZjZWJUazBQckxRND…
3 Auburn Players Who Could Break Out, Boost Stock in Fall Camp - Sports Illustrated
<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxOcU1hc0xUeWxJcEU3RFAyeFh0am5BZ3kxellGSl8xU1FVYzN3eW1ZekVBYmQ5M0VPUXViMGd6SVJoUFdQbHhaemYzTlVqTTFlbmRXdjM5ZDdXbG1DWkVHVnBzTlBCU0NTQThGZXRhdHRYSnJUX2FocUdUdUp5VEc2eVJqNHBoVVJqc1VHTU…
Auburn National Posts $2.3M as Credit Provision Turns Negative - Stock Titan
<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxPUkRyWmhUM2FxSi1rM3RCVmtsNElpWS0wVFdMaGUyU0xxcUxienhPU1FwNi1BT1h0cnF2Q2NJVXR2SFU1cXhQMHd2MGFGYk1RQUh6ZzVndTJGQncxczB0dHRXbmtEdENnSFpWbThMdzRNZ195RVZvTGVTZEl2aGRkMU5XMFVJb0tZXzB3SE…
Auburn National AUBN Q2 Earnings Rise to $2.3 Million - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxOd0sxUy1ITFJydjNKaHFvYlpFWUU5aGVIRk02aktOOHJGY1hFRm9lV0tadUdIUDk3YjZGWDgxeHd2VTFybFFqUU1ITWxrMUtDcm14QlFNbDU1bmV1clFEdzdnNUlxbDJHdm1kVl9qbXNOWnpCNTNyMU91YXI0c3EyTEtaQzYxWXIyaWx1b1…
AUBN|Auburn National Bancorporation Inc|Price:26.175| - TradingKey
<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE5nWnJWT1YybkdoWEY0RWtoaXlPSVFOZ0szUVVIMUk2OUdValY0LWN2RkRScjAxRTB5S2pfTmhYa3ljZGhlZ004T1hfWmRISG43N2VrZFFfMGpLRVVrMDFrMWZUNnl3VEFGTG0ydTZ3?oc=5" target="_blank">AUBN|Auburn Nationa…
Auburn National Bancorporation, Inc. Revenue Breakdown – NASDAQ:AUBN - TradingView
<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTFBiZjhCVnpKVUtCbkttdmFzWWFfYzliZUhPOUpudDZxd2FQdEhBejVEUktyRXlLdHFYQUotNTlXVm01algxbFBhSlJPdnRISWlJbVRIbU5wUlM3Y2FiWjBGM1ZCSF9ybnpKalIzUy04Y3IybThRMVBV?oc=5" target="_blank">Auburn …
AUBN — Frequently Asked Questions
What is the current share price of AUBN?
As of 2026-08-05 17:25 PDT, AUBN trades at $26.26 on NASDAQ/NYSE. Its 52-week range is $20.78 to $28.88.
What is the P/E ratio of AUBN?
AUBN trades at a trailing price-to-earnings (P/E) ratio of 12.62.
Is AUBN a good stock to buy?
This page provides a data-driven analysis of AUBN, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.